Structure-activity relationships of ω-conotoxins at N-type voltage-sensitive calcium channels

Journal of Molecular Recognition

Volumn 13, Issue 2, 2000, Pages 55-70

  Nielsen, Katherine J ^a   Schroeder, Tina ^a   Lewis, Richard ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Agricultural Biotechnology Centre   (Australia)

Author keywords

Conotoxin; NMR spectroscopy; Structure activity relationships

Indexed keywords

CALCIUM CHANNEL; CVID CONOTOXIN; GVIA CONOTOXIN; LIGAND BINDING; MV11A CONOTOXIN; MVIIC CONOTOXIN; OMEGA CONOTOXIN; PAIN MANAGEMENT; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OMEGA-CONOTOXINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RADIOLIGAND ASSAY; SNAILS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034060567     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1352(200003/04)13:2<55::AID-JMR488>3.0.CO;2-O     Document Type: Review

References (70)

1. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, Lewis RJ. 1998. Conotoxins and their potential pharmaceutical applications. Drug. Devel. Res. 46: 219-234.
2. Andrews PR, Craik DJ, Martin JL. 1984. Functional group contributions to drug receptor interactions. J. Med. Chem. 27: 1648-1657.
3. Basus VJ, Nadasdi L, Ramachandran J, Miljanich GP. 1995. Solution structure of omega-conotoxin MVIIA using 2D NMR spectroscopy. FEBS Lett. 370: 163-169.
4. Brose WG, Gutlove DP, Luther RR, Bowersox SS, McGuire D. 1997. Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain. Clin. J. Pain. 13: 256-259.
5. Bowersox SS, Valentino KL, Luther RR. 1994. Neuronal voltage-sensitive calcium channels. Drugs News Perspect. 7: 261-268.
6. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX, Luther RR. 1996. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol. Exp. Ther., 279: 1243-1249.
7. 1H NMR of ω-conotoxin MVIID, a calcium channel blocker peptide. Biochem. Biophys. Res. Commun. 254: 32-35.
8. Cruz LJ, Olivera BM. 1986. Calcium channel antagonists. ω-Conotoxin defines a new high affinity site. J. Biol. Chem. 261: 6230-6233.
9. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, Moczydlowski E. 1985. Conus geographus toxins that discriminates between neuronal and muscle sodium channels. J. Biol. Chem. 260: 9280-9288.
10. Currie KP, Fox AP. 1997. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. J. Neurosci. 17: 4570-4579.
11. Daly NL, Koltay A, Gustafson KR, Boyd MR, Casas-Finet JR, Craik DJ. 1999. Solution structure by NMR of Circulin A: a macrocyclic knotted peptide having anti-HIV activity. J. Mol. Biol. 285: 333-345.
12. Davis JH, Bradley EK, Miljanich GP, Nadasdi L, Ramachandran J, Basus VJ. 1993. Solution structure of omega-conotoxin GVIA using 2-D NMR spectroscopy and relaxation matrix analysis. Biochemistry 32: 7396-7405.
13. Drinkwater RD, Lewis RJ, Alewood PF, Nielsen KJ. 1999. Novel omega conotoxin peptides. Patent WO9954350A1.
14. Ellinor PT, Zhang J, Home WA, Tsien RW. 1994. Structural determinents of the blockade of N-type calcium channels by a peptide neurotoxin. Nature 372: 272-275.
15. 1H NMR spectroscopy and complete relaxation matrix analysis. J. Mol. Biol. 248: 106-124.
16. Fern R, Ransom BR, Waxman SG. 1995. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J. Neurophysiol. 74: 369-377.
17. Fletcher JI, Smith R, O'Donoghue SI, Nilges M, Connor M, Howden MEH, Christie MJ, King GK. 1997. The structure of a novel insecticidal neurotoxin, atracotoxin-HV1, from the venom of an Australian funnel web spider. Nat. Struc. Biol. 4: 559-566.
18. Flinn JP, Pallaghy PK, Lew MJ, Murphy R, Angus JA, Norton RS. 1999. Roles of key functional groups in co-conotoxin GVIA. Eur. J. Biochem. 262: 447-455.
19. Hill JM, Alewood PF, Craik DJ. 1997. Solution structure of the sodium channel antagonist conotoxin GS: a new molecular caliper for probing sodium channel geometry. Structure 5: 571-583.
20. 2+ channels. Neuron 9: 69-77.
21. Justice A, Singh T, Gohil KC, Valentino KL, Miljanich GP. 1999. Methods for producing analgesia, United States Patent 5,859,186; International Patent Classification, A61K 038/00, C07K 005/00, C07K 007/00.
22. Kamei K, Takano R, Miyasaka A, Imoto T, Hara S. 1992. Amino acid sequence of sweet-taste-suppressing peptide (gurmarin) from the leaves of Gymnema sylvestre. J. Biochem. (Tokyo), 111: 109-112.
23. Kim J-I, Takahashi M, Ogura A, Kohno T, Kudo Y, Sato K. 1994. Hydroxyl group of Tyr13 is essential for the activity of ω-conotoxin GVIA, a peptide toxin for N-type calcium channel. J. Biol. Chem. 269: 23876-23878.
24. Kim J-I, Takahashi M, Ohtake A, Wakamiya A, Sato K. 1995. Tyr13 is essential for the activity of ω-conotoxin MVIIA and GVIA specific N-type calcium channel blockers. Biochem. Biophys. Res. Commun. 206: 449-454.
25. Kohno T, Kim JI, Kobayashi K, Kodera Y, Maeda T, Sato K. 1995. Three-dimensional structure in solution of the calcium channel blocker omega-conotoxin MVIIA. Biochemistry 34: 10256-10265.
26. Kristipati R, Nadasdi L, Tarczy-Hornoch K, Lau K, Miljanich GP, Ramachandran J, Bell JR. 1994. Characterization of the binding of ω-Conopeptides to different classes of non-L-type neuronal calcium channels. Mol. and Cell. Neurosc. 5: 219-228.
27. Lew MJ, Flinn JP, Pallaghy PK, Murphy R, Whorlow SL, Wright CE, Norton RS, Angus JA. 1997. Structure-function relationships of ω-conotoxin GVIA. J. Biol. Chem. 272: 12014-12023.
28. Lewis RJ, Adams DA, Sharpe IA, Loughnan ML, Bond T, Thomas L, Jones A, Matheson J-L, Drinkwater R, Nielsen KJ, Andrews PR, Craik DJ, Alewood PF. Structure and activity of novel ω-conopeptides from Conus catus. (unpublished).
29. 2+ channel in rat sympathetic ganglia and brain. Neuron 18: 153-166.
30. Malmberg AB, Yaksh TL. 1995. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60: 83-90.
31. McDonough SI, Swartz KJ, Mintz IM, Boland LM, Bean BP. 1996. Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J. Neurosci. 16: 2612-23.
32. McGuire D, Bowersox S, Fellmann JD, Luther RR. 1997. Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans. J. Cardiovasc. Pharmacol. 30: 400-403.
33. McIntosh M, Cruz LJ, Hunkapiller MW, Gray WR, Olivera BM. 1982. Isolation and structure of a peptide toxin from the marine snail Conus magus. Arch. Biochem. Biophys. 218: 329-334.
34. Miljanich GP, Ramachandran J. 1995. Antagonists of neuronal calcium channels: structure, function and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 35: 707-734.
35. Miljanich GP, Bowersox SS, Fox JA, Valentino KL, Bitner RS, Yamashiro DH. 1993. Compositions for delayed treatment of ischemia-related neuronal damage. Publication no. WO 93/ 10145; International application no. PCT/US92 09766; International Patent Classification, C07K 7/10, A61K 37/02.
36. Myers RA, Cruz LJ, Rivier JE, Olivera BM. 1993. Conus peptides as chemical probes for receptors and ion channels. Chemical Review 93: 1923-1936.
37. Nadasdi L, Yamashiro D, Chung D, Tarczyhornoch K, Adriaenssens P, Ramachandran J. 1995. Structure-activity analysis of a Conus peptide blocker of N-type neuronal calciunn channels. Biochemistry 34: 8076-8081.
38. Narasimhan L, Singh J, Humblet C, Guruprasad K, Blundell T. 1994. Snail and spider toxins share a similar tertiary structure and 'cystine motif'. Nat. Struc. Biol. 1: 850-2.
39. Nebe J, Vanegas H, Schaible H-G. 1998. Spinal application of omega-conotoxin GVIA, an N-type calcium channel antagonist, attenuates enhancement of dorsal spinal neuronal responses caused by intra-articular injection of mustard oil in the rat. Exp. Brain. Res. 120: 61-69.
40. Nemoto N, Kubo S, Yoshida T, Chino N, Kimura T, Sakakibara S, Kyogoku Y, Kobayashi Y. 1995. Solution structure of omega-conotoxin MVIIC determined by NMR. Biochem. Biophys. Res. Commun. 207: 695-700.
41. Neugebauer V, Vanegas H, Nebe J, Rümenapp P, Schaible H-G. 1996. Effects of N- and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint. J. Neurophys. 76: 3740-3749.
42. Nielsen KJ, Thomas L, Lewis RJ, Alewood PF, Craik DJ. 1996. A consensus structure for ω-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: Comparison of MVIIA, SVIB, and SNX-202. J. Mol. Biol. 263: 297-310.
43. Nielsen KJ, Adams DA, Alewood PF, Lewis RJ, Thomas L, Schroeder T, Craik DJ. 1999a. Effects of chirality at tyr13 on the structure-activity relationships of omega-conotoxins from conus magus. Biochemistry 38: 6741-51.
44. Nielsen KJ, Adams D, Thomas L, Bond TJ, Alewood PF, Craik DJ, Lewis RJ. 1999b. Structure-activity relationships of ω-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N- and P/Q-type calcium channels. J. Mol. Biol. 289: 1405-21.
45. Nilges M, Habazettl J, Brunger AT, Holak TA. 1991. Relaxation matrix refinement of the solution structure of squash trypsin inhibitor. J. Mol. Biol. 219: 499-510.
46. Olivera BM, McIntosh JM, Cruz LJ, Luque FA, Gray WR. 1984. Peptide neurotoxins from fish-hunting cone snails. Biochemistry 23: 5087-5090.
47. Olivera BM, Gray WR, Zeikus R, McIntosh JM, Varga J. 1985. Peptide neurotoxins from fish-hunting cone snails. Science 230: 1338-1343.
48. Olivera BM, Rivier J, Clark C, Ramilo CA, Corpuz GP, Abogadie FC, Mena EE, Woodward SR, Hillyard DR, Cruz LJ. 1990. Diversity of Conus neuropeptides. Science 249: 257-263.
49. Olivera BM, Rivier J, Scott JK, Hillyard DR, Cruz LJ. 1991. Conotoxins. J. Biol. Chem. 266: 22067-22070.
50. Omote K, Kawamata M, Satoh O, Iwasaki H, Namiki A. 1996. Spinal antinociceptive action of an N-type voltage-dependent calcium channel blocker and the synergistic interaction with morphine. Anesthesiology 84: 636-643.
51. Pallaghy PK, Norton RS. 1999. Refined solution structure of omega-conotoxin GVIA: implications for calcium channel binding. J. Peptide Res. 53: 343-351.
52. Pallaghy PK, Duggan BM, Pennington MW, Norton RS. 1993. Three-dimensional structure in solution of the calcium channel blocker ω-conotoxin. J. Mol. Biol. 234: 405-420.
53. Pallaghy PK, Nielsen KJ, Craik DJ, Norton RS. 1994. A common structural motif incorporating a cystine knot and a triple-stranded β-sheet in toxic and inhibitory polypeptides. Protein Sci. 3: 1833-1839.
54. Ramilo CA, Zafaralla GC, Nadasdi L, Hammerland LG, Yoshikami D. 1992. Novel α- and ω-conotoxins from Conus striatus venom. Biochemistry 31: 9919-9926.
55. Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG. 1995. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry 34: 4147-4158.
56. Sato K, Raymond C, Martin-Moutot M, Sasaki T, Omori A, Ohtake A, Kim JI, Kohno T, Takahashi M, Seagar M. 1997. Binding of chimeric analogs of ω-conotoxin MVIIA and MVIIC to the N- and P/Q-type calcium channels. FEBS Lett. 414: 480-484.
57. Scanlon MJ, Naranjo D, Thomas L, Alewood PF, Lewis RJ, Craik DJ. 1997. Solution structure and proposed binding mechanism of a novel potassium channel toxin k-conotoxin PVIIA. Structure 5: 1585-1597.
58. Seabrook GR, Adams DJ. 1989. Inhibition of neurally-evoked transmitter release by calcium channel antagonists in rat parasympathetic ganglia. Br. J. Pharmacol. 97: 1125-1136.
59. 1H NMR. Biochem. Biophys. Res. Commun. 192: 1238-1244.
60. + channel. J. Biol. Chem. 273: 33-38.
61. Skalicky JJ, Metzler WJ, Ciesla DJ, Galdes A, Pardi A. 1993. Solution structure of the calcium channel antagonist omega-conotoxin GVIA. Protein Sci. 2: 1591-1603.
62. Sluka KA. 1997. Blockade of calcium channels can prevent the onset of secondary hyperalgesia and allodynia induced by intradermal injection of capsaicin in rats. Pain 71: 157-164.
63. Small DL, Monette R, Buchan AM, Morley P. 1997. Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation. Brain Res. 753: 209-218.
64. Takahashi T, Momiyama A. 1993. Different types of calcium channels mediate central synaptic transmission. Nature 366: 156-158.
65. Wang Y-X, Bezprozvannaya S, Bowersox SS, Nadasdi L, Miljanich G, Mezo G, Silva D, Tarczy-Hornoch K, Luther RR. 1999. Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockers. Nauyn-Schmiedeberg's Arch. Pharmacol. 357: 159-168.
66. 2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J. Neurosci. 18: 6319-6330.
67. White DM, Cousin MJ. 1998. Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Res. 801: 50-58.
68. Wu LG, Saggau P. 1997. Presynaptic inhibition of elicited neurotransmitter release. Trends in Neurosci. 20: 204-212.
69. Yamada K, Teraoka T, Morita S, Hasegawa T, Nabeshima T. 1994. Omega-conotoxin GVIA protects against ischemia-induced neuronal death in the Mongolian gerbil but not against quinolinic acid-induced neurotoxicity in the rat. Neuropharmacology 33: 251-254.
70. Yanagawa Y, Abe T, Satake M, Odani S, Suzuki J, Ishikawa K. 1988. A novel sodium channel inhibitor from Conus geographus: purification, structure, and pharmacological properties. Biochemistry 27: 6256-6262.